SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the ...
SEATTLE, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Kineta, Inc. (KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune ...
EQS-Ad-hoc: Corestate Capital Holding S.A. / Key word(s): Restructure of Company/Personnel Corestate Capital Holding S.A.: Corestate decides to implement an alternative restructuring concept and ...
BOSTON and LOUISVILLE, Ky., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (TALS), today announced that it has completed a review of its business and program prospects. Based on this ...
The Company has filed the unaudited financial results for the third quarter of 2025 ending September 30, 2025. The Company has closed its Las Vegas and Grand Rapids facility to consolidate production, ...
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- IMV Inc. (the “Company” or “IMV”) (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical Company developing a portfolio of ...
SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (NasdaqCM: BIOC) today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder value. Biocept has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback